Attached files
| file | filename |
|---|---|
| 10-K - BIOMEDICAL TECHNOLOGY SOLUTIONS HOLDINGS INC | f10k1209v12clean.htm |
| EX-31 - BIOMEDICAL TECHNOLOGY SOLUTIONS HOLDINGS INC | exh311209.htm |
| EX-10.2 - SETTLEMENT AGREEMENT DUDZIAK / WED - BIOMEDICAL TECHNOLOGY SOLUTIONS HOLDINGS INC | dudziakwedsettlementagreemen.htm |
| EX-10.1 - SETTLEMENT AGREEMENT MALIBU - BIOMEDICAL TECHNOLOGY SOLUTIONS HOLDINGS INC | settlementagrreleasev2cleanc.htm |
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of BioMedical Technology Solutions Holdings, Inc. (the "Company") on Form 10-K for the fiscal year ended December 31, 2009, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), we, Donald G. Cox, Chief Executive Officer/President and David A. Kempf, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and | |
(2) | The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company. |
_/s/ Donald G. Cox________
Donald G. Cox
Chief Executive Officer/President
May 13, 2010
__/s/ David A. Kempf________
David A. Kempf
Chief Financial Officer
May 13, 2010